What Is Tryptase and Why Are My Levels High?

Tryptase is an enzyme stored inside mast cells, and it enters your bloodstream whenever those cells activate or when your body simply has too many of them. A high tryptase level can point to anything from a severe allergic reaction in progress to a genetic trait you were born with, a blood disorder, or even reduced kidney function. The test is deceptively simple — a single number on a lab report — but interpreting what that number means requires context about when and why it was drawn.

What Tryptase Actually Does

Tryptase is a protein-cutting enzyme (a serine protease) and the single most abundant substance packed into mast cell granules. When a mast cell degranulates — the technical way of saying it dumps its contents into surrounding tissue — tryptase pours out along with histamine, heparin, and other inflammatory mediators.¹ Mast cells are stationed throughout your skin, gut lining, and airways, where they serve as sentinels for the immune system. Once released, tryptase can chop up proteins in surrounding tissue, activate other inflammatory pathways, and recruit more immune cells to the area.

The enzyme works in an unusual way: it functions as a four-unit cluster held together by heparin, which makes it resistant to most of the body’s natural protease inhibitors.² That resistance is part of why tryptase can do so much damage during a prolonged allergic or inflammatory episode — the body has trouble shutting it down once it is loose. Researchers have linked tryptase activity to the pathology of asthma, inflammatory skin conditions, and tissue remodeling in the lungs.

The Two Forms That Matter for Your Lab Results

Your body makes two main forms of tryptase: alpha and beta. For years, alpha-tryptase was assumed to be the primary form circulating in blood at rest. That understanding has been revised. The baseline tryptase circulating when nothing acute is happening consists mostly of an inactive precursor called pro-beta-tryptase, which mast cells secrete continuously rather than storing it in granules.³ When mast cells degranulate during an allergic reaction, the mature, active beta-tryptase floods out of the granules on top of that baseline level. Standard lab assays measure total tryptase — they do not distinguish between the inactive precursor trickling out at rest and the active form released during a reaction. That distinction matters because a high baseline level and a high acute level point to very different problems.

What Counts as a Normal Tryptase Level

The commercial assay commonly used in labs sets its upper limit of normal at 11.4 ng/mL. However, expert groups in Europe and North America have pushed for a broader normal range of 1 to 15 ng/mL, which better accounts for natural variation among healthy people.⁴ Several factors influence where a healthy person’s baseline sits: how many mast cells they have, how fast those cells secrete the inactive precursor, kidney function, and critically, how many copies of a particular gene (TPSAB1) they carry.⁵

If your doctor ordered a tryptase level and it came back above 11.4 ng/mL, that does not automatically mean something is wrong. Conversely, a level that falls within the lab’s “normal” range does not rule out a problem — especially if the test was drawn at the wrong time during an acute reaction. Context is everything with this particular lab value.

Anaphylaxis and the Timing Window

The most common reason doctors order a tryptase test on short notice is to confirm or rule out anaphylaxis. During a severe allergic reaction, mast cells throughout the body degranulate at once, and tryptase levels spike. But the spike follows a specific timeline that is easy to miss. In experimentally induced anaphylaxis from bee stings, tryptase peaked one to two hours after the sting, not immediately. During the first 15 to 30 minutes, levels may not be detectably elevated at all. After peaking, tryptase declines with a half-life of roughly two hours.⁶ This makes tryptase very different from histamine, which peaks within minutes and disappears quickly.

The practical takeaway: a blood draw taken too early (within the first 15 minutes) or too late (more than six hours after the reaction) can return a falsely normal result. Best practice calls for drawing blood between one and two hours after symptom onset. Because interpreting a single acute value can be tricky, clinicians sometimes compare the acute sample to a baseline level drawn days later, once the patient has fully recovered. An acute-to-baseline ratio above roughly 1.74 showed strong diagnostic performance in one pediatric study, outperforming the older consensus formula for confirming anaphylaxis in children.⁷

Hereditary Alpha-Tryptasemia

If your baseline tryptase is persistently above 8 ng/mL with no obvious allergic or hematologic explanation, your doctor may consider a genetic trait called hereditary alpha-tryptasemia, or HαT. This is not a disease in the traditional sense — it is an inherited variation in which you carry extra copies of the TPSAB1 gene that encodes alpha-tryptase. The trait is autosomal dominant (one copy from one parent is enough) and is found in roughly 4 to 6 percent of the general population, making it far more common than most people expect.⁸

The elevated tryptase in HαT comes from increased production and secretion of the pro-alpha-tryptase precursor, not from mast cells going haywire. It is essentially a factory-output issue, not an activation issue. Both the tryptase level and the severity of symptoms track with gene dosage: the more extra copies of TPSAB1 you carry, the higher your tryptase and the more likely you are to have symptoms.⁹ About a third of people with HαT experience associated symptoms, which can span skin flushing, gastrointestinal complaints, joint hypermobility, autonomic dysfunction (like dizziness on standing), and even neuropsychiatric effects.⁸ The remaining two-thirds carry the trait without noticeable trouble.

HαT was only formally described in 2016, which means many people walking around with mildly elevated tryptase levels were previously subjected to extensive and sometimes invasive workups for mastocytosis or mast cell activation syndrome when the explanation was genetic all along. If your family members also have elevated tryptase, the genetic explanation becomes more likely.

Mastocytosis and Other Blood Disorders

A persistently elevated baseline tryptase is one of the minor diagnostic criteria for systemic mastocytosis, a condition in which abnormal mast cells accumulate in bone marrow and other organs.¹⁰ In mastocytosis, the high tryptase reflects a genuine overload of mast cells, often driven by a mutation in the KIT gene (D816V). The burden of that mutation correlates with tryptase levels, so higher tryptase readings generally signal a larger population of abnormal mast cells.¹¹ Mastocytosis can range from an indolent skin-only form that mainly causes itchy brown spots to aggressive systemic disease affecting the bone marrow and internal organs.

Tryptase elevation is not limited to mastocytosis, though. It clusters in myeloid blood cancers more broadly. In one study, elevated tryptase (above 15 ng/mL) was found in over 90 percent of patients with systemic mastocytosis, about 38 percent of those with acute myeloid leukemia, roughly a third of chronic myeloid leukemia patients, and a quarter of those with myelodysplastic syndromes. Patients with lymphoid cancers almost always had normal tryptase.¹² This pattern has led some researchers to propose tryptase as a useful screening biomarker in hematology beyond its traditional allergy-related role.¹³

Kidney Disease Can Raise Tryptase Too

A cause of elevated tryptase that often gets overlooked is impaired kidney function. Because tryptase is cleared at least partly through the kidneys, people with advanced chronic kidney disease tend to accumulate higher levels. In one study, patients with stage 4 or 5 kidney disease and those on hemodialysis had average tryptase levels roughly double those of patients with early-stage kidney disease. The estimated glomerular filtration rate and proteinuria were both independent predictors of tryptase levels in that population.¹⁴ If you have known kidney problems, your doctor should factor that into the interpretation of any tryptase result before pursuing an allergy or hematology workup.

When the Lab Test Itself Gets It Wrong

Occasionally, a high tryptase reading is not caused by anything happening in your body — it is caused by something interfering with the assay. The most well-documented culprit is heterophilic antibodies, particularly IgM rheumatoid factor (RF). These antibodies can cross-link the assay reagents in a way that produces a falsely elevated result. In one study of 83 samples positive for rheumatoid factor, about 17 percent showed a significant drop in measured tryptase after a blocking step was applied. More than half of those reverted from elevated to normal-range values, with falls as large as 98 percent.¹⁵

Human anti-mouse antibodies (HAMA), which some patients develop after receiving mouse-derived diagnostic or therapeutic agents, can cause the same kind of interference.¹⁶ If your tryptase comes back elevated but nothing else in your clinical picture fits, asking your doctor whether assay interference could be a factor is reasonable — especially if you have rheumatoid arthritis or another condition associated with high rheumatoid factor.

Baseline Tryptase and Insect Sting Severity

One of the most clinically useful applications of a baseline tryptase measurement is predicting how severely someone with insect venom allergy will react to future stings. In a large European study, the frequency of severe systemic anaphylactic reactions after field stings rose significantly with higher baseline tryptase, in a nonlinear pattern — meaning the risk climbed steeply past a certain threshold. Other factors like older age, male sex, and use of certain blood pressure medications also contributed.¹⁷ Elevated baseline tryptase was also significantly correlated with the severity of initial allergic reactions to wasp stings specifically, and mastocytosis itself is a known risk factor for fatal sting reactions.¹⁸

For people with insect venom allergy, knowing your baseline tryptase is not just academic — it directly influences treatment decisions. Allergists may recommend lifelong venom immunotherapy rather than the standard five-year course if your baseline is elevated, and they will monitor you more closely during the desensitization process.

Tryptase, Airway Remodeling, and Itch

Beyond its role as a diagnostic marker, tryptase itself appears to drive disease processes. In the lungs, tryptase promotes airway remodeling — the structural changes that make asthma worse over time. Laboratory studies show that tryptase boosts the growth of bronchial and alveolar epithelial cells, shortens the time between cell divisions, and increases production of anti-apoptotic proteins that help these cells resist programmed death. The result is thickened, inflamed airway tissue.¹⁹ Tryptase also contributes to fibrosis and turnover of the extracellular matrix in airway walls, which is a hallmark of the remodeling process that makes chronic asthma increasingly difficult to reverse.²⁰

In the skin, tryptase plays a role in itch signaling. It activates a receptor called PAR-2 on nerve endings and skin cells, which triggers scratch-inducing signals. In mouse models of allergic dermatitis, blocking tryptase or the PAR-2 receptor reduced mast cell degranulation and significantly cut down scratching behavior.²¹ This connection between tryptase and itch is one reason researchers are interested in developing drugs that target the enzyme directly.

Tryptase and Heart Disease

An emerging research area links tryptase to cardiovascular disease. Mast cells are found in atherosclerotic plaques, and their degranulation products — tryptase included — may contribute to plaque instability. In one Chinese population study, tryptase levels were nearly doubled in patients with acute heart attacks compared to those without significant coronary disease, and remained significantly higher even after adjusting for traditional cardiac risk factors.²² The findings are still considered preliminary and population-specific, but they suggest tryptase could eventually serve as a marker for vulnerable plaques, not just for allergic conditions.

Tryptase Inhibitors as Future Treatments

Because tryptase does not just signal mast cell activation but actively drives tissue damage, blocking it pharmacologically has been a goal for decades. Several classes of synthetic tryptase inhibitors have been developed and tested in animal models. In allergic sheep, aerosol delivery of tryptase inhibitors before and after allergen exposure abolished the late-phase bronchoconstriction and airway hyperresponsiveness that mimic a human asthma attack. Intradermal injection of one such inhibitor, APC-366, blocked the allergic skin response as well.²³ The promise is that unlike antihistamines (which only block one product of mast cell degranulation), tryptase inhibitors could address the tissue-remodeling component of chronic allergic disease. None have reached routine clinical use yet, and translating animal-model success into effective human therapeutics has proven slow. Still, the proof-of-concept data keep tryptase on the list of viable drug targets for asthma and inflammatory conditions.

Postmortem Tryptase in Forensic Medicine

One application of tryptase testing most people never encounter is in forensic pathology. When someone dies unexpectedly and anaphylaxis is suspected, pathologists measure tryptase in postmortem blood to help establish or rule out an allergic cause of death. Biochemical studies have reported elevated postmortem beta-tryptase in anaphylaxis-related deaths, with proposed diagnostic thresholds ranging from roughly 30 to 64 micrograms per liter — far above anything seen in living patients at baseline.²⁴ However, tryptase can also rise after death from non-allergic causes (agonal mast cell degranulation during the dying process, for instance), so forensic experts interpret the result alongside autopsy findings, scene investigation, and medical history rather than relying on the number alone.²⁵